FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / lock-up-waiver-request-broadmark.docx
lock-up-waiver-request-broadmark.docx · 1018-00001

Parties

Broadmark Capital Inc
Penterra Pharmaceuticals Corp
Ridgeline Securities LLC
Castellano Family Holdings LLC
Harkness LLP
Corporate Secretary Penterra Pharmaceuticals Corp
Garza LLP

Dates

September 18, 2023
April 17, 2023
April 12, 2023
October 14, 2023
July 28, 2023
August 22, 2023
October 2, 2023
October 12, 2023
October 17, 2023
January 15, 2024

Amounts

$0.001
$22.00
$528,000,000
$36,960,000
$4,200,000
$486,840,000
$41.60
$260,000,000

Obligations

Any shares not sold in the Secondary Offering (including shares subject to the Over-Allotment Option that are not purchased by the underwriters) shall remain subject to the lock-up restrictions until the natural expiration of the Lock-Up Period
(d) The requested waiver is a one-time accommodation and shall not be construed as establishing a precedent for future waivers or releases
Attn: Diane Chaudhary, Managing Director 600 Lexington Avenue New York, NY 10022 The lock-up waiver shall not become effective unless and until written consent is received from all three IPO Underwriters (i